07:00 , Sep 27, 2000 |  BC Extra  |  Company News

Berlex and Dusa receive approval

The FDA granted Berlex (Montville, N.J.) and DUSA marketing approval for the commercial version of the BLU-U Blue Light Photodynamic Therapy (PDT) Illuminator, used exclusively with DUSA's Levulan aminolevulinic acid (ALA) PDT system to treat...
07:00 , Apr 25, 1994 |  BC Week In Review  |  Clinical News

Topical ALA photodynamic therapy: Began Phase II trials

DUSA Pharmaceuticals Inc. (DUSA), Toronto   Product: Topical ALA photodynamic therapy   Indication: Superficial basal cell carcinomas   Status: Began Phase II trials in 60 patients. Because previous studies of ALA PDT have reported cure...